All About Multiple Sclerosis

More MS news articles for September 2003

GRO-alpha and CXCR2 in the Human Fetal Brain and Multiple Sclerosis Lesions

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12966224&dopt=Abstract

Dev Neurosci. 2003;25(2-4):279-90
Filipovic R, Jakovcevski I, Zecevic N.
Department of Neuroscience, University of Connecticut Medical School, Farmington, Conn., USA.

Chemokines, small proinflammatory cytokines, are involved in migration of inflammatory cells, but also have a role in normal central nervous system development.

One chemokine, growth-related oncogene-alpha (GRO-alpha) and its receptor CXCR2, are involved in proliferation and migration of oligodendrocyte progenitors in rats.

Here we studied the regional and cell type-specific expression of GRO-alpha and CXCR2 in the human telencephalon at midgestation, the time that oligodendrocytes are being generated in the human brain.

Our results showed that both GRO-alpha and CXCR2 are predominately expressed by oligodendrocyte progenitors and activated microglial cells in the highly proliferative subventricular zone.

This cellular and regional localization suggests that GRO-alpha/CXCR2 may play a role in human oligodendrocyte proliferation and subsequent migration.

We also studied the expression of GRO-alpha and CXCR2 in brain sections of multiple sclerosis (MS) patients.

Consistent with their role in the inflammatory process of MS, both GRO-alpha and CXCR2 were expressed in activated microglia localized on the border of MS lesions.

However, neither GRO-alpha nor CXCR2 were present in early oligodendrocyte progenitors, a finding that may partially explain why remyelination is not more efficient in MS.